The major central endocannabinoid directly acts at GABA(A) receptors.
about
Structure, function, and modulation of GABA(A) receptorsWhy do cannabinoid receptors have more than one endogenous ligand?Monoacylglycerol lipase - a target for drug development?"Redundancy" of endocannabinoid inactivation: new challenges and opportunities for pain controlLatest advances in the discovery of fatty acid amide hydrolase inhibitorsElevating endocannabinoid levels: pharmacological strategies and potential therapeutic applicationsMonoacylglycerols activate TRPV1--a link between phospholipase C and TRPV1Reversible disruption of pre-pulse inhibition in hypomorphic-inducible and reversible CB1-/- mice.Effects of WIN 55,212-2 (a non-selective cannabinoid CB1 and CB 2 receptor agonist) on the protective action of various classical antiepileptic drugs in the mouse 6 Hz psychomotor seizure model.ABHD6 blockade exerts antiepileptic activity in PTZ-induced seizures and in spontaneous seizures in R6/2 mice.Molecular analysis of the site for 2-arachidonylglycerol (2-AG) on the β₂ subunit of GABA(A) receptors.The major brain endocannabinoid 2-AG controls neuropathic pain and mechanical hyperalgesia in patients with neuromyelitis optica.Endocannabinoid signalling and the deteriorating brainA common molecular basis for exogenous and endogenous cannabinoid potentiation of glycine receptorsEvidence for bidirectional endocannabinoid transport across cell membranesTime-coded neurotransmitter release at excitatory and inhibitory synapses.Brain 2-Arachidonoylglycerol Levels Are Dramatically and Rapidly Increased Under Acute Ischemia-Injury Which Is Prevented by Microwave Irradiation.Endocannabinoids: A Promising Impact for Traumatic Brain Injury.Sticking out of the crowd: the molecular identity and development of cholecystokinin-containing basket cells.PUFA-derived endocannabinoids: an overview.Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid-neurotrophin interactions.No more pain upon Gq-protein-coupled receptor activation: role of endocannabinoids.Pain in neuromyelitis optica--prevalence, pathogenesis and therapy.Rising stars: modulation of brain functions by astroglial type-1 cannabinoid receptors.Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease.Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study.Cannabimimetic phytochemicals in the diet - an evolutionary link to food selection and metabolic stress adaptation?Structural Studies of GABAA Receptor Binding Sites: Which Experimental Structure Tells us What?Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent Mechanism.Do N-arachidonyl-glycine (NA-glycine) and 2-arachidonoyl glycerol (2-AG) share mode of action and the binding site on the β2 subunit of GABAA receptors?Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms.Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state.Cell-Autonomous Excitation of Midbrain Dopamine Neurons by Endocannabinoid-Dependent Lipid Signaling.Effects of unsaturated fatty acids on the kinetics of voltage-gated proton channels heterologously expressed in cultured cells.CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity.The endocannabinoid system in guarding against fear, anxiety and stress.Neurophysiological evidence for the presence of cannabinoid CB1 receptors in the laterodorsal tegmental nucleus.In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048).Differential regulation of NMDAR and NMDAR-mediated metaplasticity by anandamide and 2-AG in the hippocampus.Analysis of γ-aminobutyric acid (GABA) type A receptor subtypes using isosteric and allosteric ligands.
P2860
Q26859328-EA8DC277-2E16-410F-91AF-A4705F846C18Q26862444-05F79A16-4443-4A0E-9033-4924C42B07F0Q26998964-11484F63-4B23-4D89-9FD5-30111230C304Q27015753-5702F02E-6C58-45BF-89C2-D775C474A3D0Q28287173-CF9B09A0-52C4-45C6-AE78-A6ADF4846084Q28300390-333300DB-B793-475A-A7FE-74AD72B9EFC7Q28535638-43B509E2-1D7A-49FB-B9AD-4AA5F5CDDDCCQ30467877-D087AEA9-A753-439C-B0AE-6737855A82EFQ33785477-5E173681-8E9F-4B4B-85FC-02A81C58B84AQ34060224-A30E29FE-30B9-4C20-8786-65E955AF786AQ34661028-8AC0F61B-C584-4537-B850-B93B936A0F59Q34949720-BEF99D24-1AFE-4A4D-BA5B-2D68F9E7F765Q35754490-3D9636E2-536D-427E-866B-587A761C5C9BQ35908392-DDEC5865-C196-413F-9D73-3148F25FD94DQ36298487-B1427B8D-0C48-42E4-B06B-D68C754463D2Q36646602-01FEB374-2C10-457B-A79C-BC537B99BF4DQ36759329-2299ECA4-CD77-49A5-8F2A-E37D8FD3D826Q37648343-2C34357C-594E-48EB-AFEA-12B9670FF57BQ37973315-857D0B92-00A9-4A5B-83D8-DA8992CEFDBAQ38135917-EB0A1652-AC1B-4214-9045-F7486E2E07B1Q38185071-79351702-4205-4C9C-9A68-9376F7AEC562Q38185075-27B9540A-80AD-4C55-940D-9A5777D21EE8Q38235026-BE589575-C055-451B-8D2A-D6366D017435Q38276026-A19824F0-C54A-4D4A-B49B-B1205E541B4EQ38566169-3A80E841-9F22-4D22-8AD8-F7DA9042D446Q38877058-854BDD87-8475-463D-AF0C-B4E99AA45AC0Q39021787-DD0723FF-3DD6-42E7-8CBF-B003D816E906Q39631476-1E6ACF8D-7692-4032-9A7E-6B75CC510CBAQ40594444-B168AB04-8042-4099-A743-02AB42EA57B9Q42078022-65299FFD-9BDC-4DE0-B833-047DD65C6FB5Q42700473-C35FA1DA-7A31-47E8-A5D6-A4C65EBB4CD1Q44435277-BD266CD8-D214-488B-8A3E-7CD8143C2A31Q45814311-BCE5295A-CA61-4C85-BF6C-3876D39A6120Q46640052-E400A5EA-1A27-4DAA-A688-F3A7E488581BQ47134613-58F3AD7C-76AF-47CF-B0F3-2678DD4D3E9EQ47618301-A937D575-4D38-4611-B2D4-E08AF3E5D5C6Q47725960-471DC121-9B07-4136-B97C-1E8CDA2B413AQ48606721-87D5D995-AD2D-48E6-807B-13806D6D5C2EQ48622819-8CA96F26-757D-449A-B38B-AD070B37A768Q48663996-CAC09A57-3D9B-44A6-AA15-E26FF356893C
P2860
The major central endocannabinoid directly acts at GABA(A) receptors.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The major central endocannabinoid directly acts at GABA
@nl
The major central endocannabinoid directly acts at GABA(A) receptors.
@en
type
label
The major central endocannabinoid directly acts at GABA
@nl
The major central endocannabinoid directly acts at GABA(A) receptors.
@en
prefLabel
The major central endocannabinoid directly acts at GABA
@nl
The major central endocannabinoid directly acts at GABA(A) receptors.
@en
P2093
P2860
P356
P1476
The major central endocannabinoid directly acts at GABA(A) receptors.
@en
P2093
Andreas Zimmer
Erwin Sigel
Ildiko Rácz
Janine Marazzi
Jürg Gertsch
Roland Baur
Trevor G Smart
P2860
P304
18150-18155
P356
10.1073/PNAS.1113444108
P407
P577
2011-10-24T00:00:00Z